
While both the S&P 500 Index ($SPX) and Nasdaq Composite ($NASX) posted new record highs on Friday, Teladoc Health (TDOC) shares fell to their all-time lows. Nothing much has gone right for the telehealth stock, and it is now down over 57% for the year.
Teladoc shares peaked above $300 in February 2021, and have been sliding ever since. The stock fell 74% in 2022 amid broad-based selling in U.S. markets. However, even as markets rebounded in 2023, and continued their winning streak in H1 2024, Teladoc Health stock has been stuck in the red.